Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3

NCT01634503 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia 3

Interventions

GENETIC: GX-188E administered by electroporation

Sponsor

Genexine, Inc.